Thoracic magnetic resonance imaging in non-tuberculous mycobacterial pulmonary disease: Characteristics and potential implementation
PLOS One · 2025
DOI: 10.1371/journal.pone.0325347 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Ieuan Edward Shepherd Evans und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Centre for Lung Infection (CCLI), Royal Papworth Hospital, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Mycobacterium Infections, Nontuberculous, Lung Diseases, Lung. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Non-tuberculous mycobacteria (NTM) are pulmonary pathogens with increasing incidence and prevalence worldwide, with people with cystic fibrosis (pwCF) traditionally considered at high risk of disease development. The imaging assessment of NTM-pulmonary disease (NTM-PD) relies heavily on high-resolution computed tomography (HRCT). However, due to lengthy treatment regimens and the need for long-term follow-up, serial HRCT’s result in progressive exposure to ionizing radiation; a particular concern in younger people.
Methods
We performed a retrospective cohort study of patients who had undergone serial thoracic magnetic resonance imaging (tMRI) scans to monitor NTM-PD as a novel tool to image the lung with a view to creating an algorithm for the utility of tMRI in the management of NTM-PD.
Results
Thirty-six patients, of which twenty-four had a diagnosis of CF, with suspected or confirmed NTM-PD underwent serial tMRI between 1 st January 2013 and 30 th June 2018. A total of 117 serial tMRI’s were performed (mean number per patient 3.25; range 2–6). The associated clinical impact that each serial MRI had on management, deemed as the utility of tMRI, found that all tMRI’s were classified as aiding management with 60 (51.3%) altering management. tMRI’s were more likely to alter management in the non-CF cohort than the CF cohort (69.4% vs. 43.2%). No imaging-related adverse events were reported across the 117 tMRI’s.
Conclusion
This study highlights that tMRI may hold promise as a monitoring tool in NTM-PD and should be prospectively evaluated in the monitoring of individuals with NTM-PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cambridge Centre for Lung Infection (CCLI), Royal Papworth Hospital, Cambridge, United Kingdom.
- Thoracic Medicine Department, The Prince Charles Hospital, Queensland, Australia.
- Faculty of Medicine, University of Queensland (UQ), Queensland, Australia.
- Respiratory Department, Sunshine Coast University Hospital, Queensland, Australia.
- Sunshine Coast Health Institute (SCHI), Queensland, Australia.
- University of the Sunshine Coast (UniSC), Queensland, Australia.
ORCID-Profile: Ieuan Edward Shepherd Evans, Dorothy Grogono
Zitieren
APA
Evans, I. E. S., Baird, T., Haworth, C. S., Johnson, C., Barker, H., Hill, U., Grogono, D., Eneje, O., Screaton, N., & Floto, A. (2025). Thoracic magnetic resonance imaging in non-tuberculous mycobacterial pulmonary disease: Characteristics and potential implementation. PLOS One. https://doi.org/10.1371/journal.pone.0325347
Vancouver
Evans IES, Baird T, Haworth CS, Johnson C, Barker H, Hill U, et al. Thoracic magnetic resonance imaging in non-tuberculous mycobacterial pulmonary disease: Characteristics and potential implementation. PLOS One. 2025. doi:10.1371/journal.pone.0325347
BibTeX
@article{Evans2025,
author = {Evans, Ieuan Edward Shepherd and Baird, Timothy and Haworth, Charles S and Johnson, Christopher and Barker, Helen and Hill, Uta and Grogono, Dorothy and Eneje, Odiri and Screaton, Nicholas and Floto, Andres},
title = {Thoracic magnetic resonance imaging in non-tuberculous mycobacterial pulmonary disease: Characteristics and potential implementation},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0325347}
}
EUVIMED